Biological roles of liver x receptors in immune cells

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 4, 2012, Pages 235-249

  Pascual García, Mónica ^a   Valledor, Annabel F ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Gene expression; Inflammation; LXR; Transrepression

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ABC TRANSPORTER A1; ABC TRANSPORTER G1; CORONIN 2A; DESMOSTEROL; INDUCIBLE NITRIC OXIDE SYNTHASE; KHELLIN; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; LOW DENSITY LIPOPROTEIN RECEPTOR; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; N,N DIMETHYL 3BETA HYDROXY CHOLENAMIDE; NUCLEAR RECEPTOR COREPRESSOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; STAT1 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; UNCLASSIFIED DRUG; WAY 252623; ZYMOSTEROL;

ATHEROSCLEROSIS; BACTERIAL INFECTION; BIOLOGICAL ACTIVITY; CELL PHAGOCYTOSIS; CELL PROLIFERATION; CHLAMYDIAL PNEUMONIA; FATTY ACID SYNTHESIS; GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; LIVER X RECEPTOR GENE; METABOLIC REGULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR GENE; RECEPTOR UPREGULATION; REVIEW; SUMOYLATION;

ANIMALS; CHOLESTEROL; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIPID METABOLISM; ORPHAN NUCLEAR RECEPTORS; PROTEIN MULTIMERIZATION; REPRESSOR PROTEINS; RETINOID X RECEPTORS;

EID: 84866520633     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0179-9     Document Type: Review

References (121)

1. A-Gonzalez N, Bensinger SJ, Hong C et al (2009) Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31:245-258
2. Arai S, Shelton JM, Chen M et al (2005) A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab 1:201-213 (Pubitemid 43960602)
3. Baldán Á, Bojanic DD, Edwards PA (2009) The ABCs of sterol transport. J Lipid Res 50(Suppl):S80-S85
4. Benkoussa M, Brand C, Delmotte M-H et al (2002) Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol 22:4522-4534 (Pubitemid 34620390)
5. Bensinger SJ, Bradley MN, Joseph SB et al (2008) LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134:97-111 (Pubitemid 351905740)
6. Blaschke F, Leppanen O, Takata Y et al (2004) Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Circ Res 95:e110-e123
7. Boergesen M, Pedersen TA, Gross B et al (2012) Genome-wide profiling of LXR, RXR and PPARa in mouse liver reveals extensive sharing of binding sites. Mol Cell Biol 32:852-867
8. Bruhn KW, Marathe C, Maretti-Mira AC et al (2010) LXR deficiency confers increased protection against visceral Leishmania infection in mice. PLoS Negl Trop Dis 4:e886
9. Cao F, Castrillo A, Tontonoz P et al (2007) Chlamydia pneumoniaeinduced macrophage foam cell formation is mediated by Tolllike receptor 2. Infect Immun 75:753-759 (Pubitemid 46203437)
10. Carrano AC, Eytan E, Hershko A et al (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193-199 (Pubitemid 129500937)
11. Castrillo A, Joseph SB, Vaidya SA et al (2003) Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 12:805-816 (Pubitemid 37352775)
12. Cha JY, Repa JJ (2007) The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 282:743-751 (Pubitemid 47076632)
13. Chang KCN, Shen Q, Oh IG et al (2008) Liver X receptor is a therapeutic target for photoaging and chronological skin aging. Mol Endocrinol 22:2407-2419
14. Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
15. Chen S, Sorrentino R, Shimada K et al (2008) Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation. J Immunol 181:7186-7193
16. Cheng O, Ostrowski RP, Liu W et al (2010) Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-kappaB. Neuroscience 166:1101-1109
17. Chuu CP, Kokontis JM, Hiipakka RA et al (2007) Modulation of liver X receptor signaling as novel therapy for prostate cancer. J Biomed Sci 14:543-553 (Pubitemid 47414761)
18. Collins JL, Fivush AM, Watson MA et al (2002) Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 45:1963-1966 (Pubitemid 34477709)
19. Commerford SR, Vargas L, Dorfman SE et al (2007) Dissection of the insulin-sensitizing effect of liver X receptor ligands. Mol Endocrinol 21:3002-3012 (Pubitemid 350223510)
20. Crisafulli C, Di PR, Mazzon E et al (2010a) Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury. J Leukoc Biol 87:309-321
21. Crisafulli C, Mazzon E, Paterniti I et al (2010b) Effects of liver X receptor agonist treatment on signal transduction pathways in acute lung inflammation. Respir Res 11:19
22. Denechaud PD, Bossard P, Lobaccaro JM et al (2008) ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest 118:956-964 (Pubitemid 351364603)
23. Durante W, Johnson FK, Johnson RA (2007) Arginase: A critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34:906-911 (Pubitemid 47083958)
24. Edwards PA, Kast HR, Anisfeld AM (2002) BAREing it all: The adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res 43:2-12 (Pubitemid 34117211)
25. Feig JE, Pineda-Torra I, Sanson M et al (2010) LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest 120:4415-4424
26. Forman BM, Ruan B, Chen J et al (1997) The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism. Proc Natl Acad Sci USA 94:10588-10593
27. Fowler AJ, Sheu MY, Schmuth M et al (2003) Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol 120:246-255 (Pubitemid 36513075)
28. Galon J, Franchimont D, Hiroi N et al (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16:61-71 (Pubitemid 34027951)
29. Geyeregger R, ZeydaM,BauerWet al (2007) LiverXreceptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin. Blood 109:4288-4295 (Pubitemid 46743395)
30. Geyeregger R, Shehata M, Zeyda M et al (2009) Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. J Leukoc Biol 86:1039-1048
31. Ghisletti S, Huang W, Ogawa S et al (2007) Parallel SUMOylationdependent pathways mediate gene-And signal-specific transrepression by LXRs and PPARgamma. Mol Cell 25:57-70 (Pubitemid 46049061)
32. Ghisletti S, Huang W, Jepsen K et al (2009) Cooperative NCoR/ SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev 23:681-693
33. Glass CK, Ogawa S (2006) Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 6:44-55 (Pubitemid 43279752)
34. Gong H, He J, Lee JH et al (2009) Activation of the liver X receptor prevents lipopolysaccharide-induced lung injury. J Biol Chem 284:30113-30121
35. Hamon Y, Broccardo C, Chambenoit O et al (2000) ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2:399-406
36. Hanley TM, Blay Puryear W, Gummuluru S et al (2010) PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection. PLoS Pathog 6:e1000981
37. Heine G, Dahten A, Hilt K et al (2009) Liver X receptors control IgE expression in B cells. J Immunol 182:5276-5282
38. Herath KB, Jayasuriya H, Guan Z et al (2005) Anthrabenzoxocinones from Streptomyces sp. as liver X receptor ligands and antibacterial agents. J Nat Prod 68:1437-1440 (Pubitemid 41499449)
39. Hindinger C, Hinton DR, Kirwin SJ et al (2006) Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J Neurosci Res 84:1225-1234 (Pubitemid 44654446)
40. Hoberg JE, Yeung F, Mayo MW (2004) SMRT derepression by the IkappaB kinase alpha: A prerequisite to NF-kappaB transcription and survival. Mol Cell 16:245-255 (Pubitemid 39388839)
41. Hörlein AJ, Näär AM, Heinzel T et al (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
42. Huang W, Ghisletti S, Saijo K et al (2011) Coronin 2A mediates actin-dependent de-repression of inflammatory response genes. Nature 470:414-418
43. Hwang EJ, Lee JM, Jeong J et al (2009) SUMOylation of RORalpha potentiates transcriptional activation function. Biochem Biophys Res Commun 378:513-517
44. 2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. Mol Cell 34:510-518
45. Janowski BA, Willy PJ, Devi TR et al (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383:728-731 (Pubitemid 26360651)
46. Janowski BA, Grogan MJ, Jones SA et al (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA 96:266-271 (Pubitemid 29036088)
47. Jayasuriya H, Herath KB, Ondeyka JG et al (2005) Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources. J Nat Prod 68:1247-1252 (Pubitemid 41291272)
48. Jiang Q, Lee CYD, Mandrekar S et al (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58:681-693 (Pubitemid 351778466)
49. Joseph SB, McKilligin E, Pei L et al (2002) Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 99:7604-7609 (Pubitemid 34568738)
50. Joseph SB, Castrillo A, Laffitte BA et al (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9:213-219 (Pubitemid 36227724)
51. Joseph SB, Bradley MN, Castrillo A et al (2004) LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119:299-309 (Pubitemid 39360910)
52. Kanno Y, Levi BZ, Tamura T et al (2005) Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J Interf Cytokine Res 25:770-779 (Pubitemid 43068488)
53. Kim KH, Lee GY, Kim JI et al (2010) Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity. J Lipid Res 51:3425-3433
54. Korf H, Vander Beken S, Romano M et al (2009) Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J Clin Invest 119:1626-1637
55. Kratzer A, Buchebner M, Pfeifer T et al (2009) Synthetic LXR agonist attenuates plaque formation in apoE-/-mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res 50:312-326
56. Kropf P, Fuentes JM, Fähnrich E et al (2005) Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J 19:1000-1002 (Pubitemid 40827731)
57. Kurokawa J, Arai S, Nakashima K et al (2010) Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab 11:479-492
58. Kurokawa J, Nagano H, Ohara O et al (2011) Apoptosis inhibitor of macrophage (AIM) is required for obesity-Associated recruitment of inflammatory macrophages into adipose tissue. Proc Natl Acad Sci USA 108:12072-12077
59. Laffitte BA, Joseph SB, Walczak R et al (2001) Autoregulation of the human liver X receptor alpha promoter. Mol Cell Biol 21:7558-7568 (Pubitemid 32988767)
60. Laffitte BA, Chao LC, Li J et al (2003) Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci USA 100:5419-5424 (Pubitemid 36542720)
61. Lee SK, Kim JH, Lee YC et al (2000) Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factorkappaB, and serum response factor. J Biol Chem 275:12470-12474 (Pubitemid 30241389)
62. Lee MH, Lu K, Hazard S et al (2001) Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27:79-83 (Pubitemid 32044523)
63. Lee JH, Park SM, Kim OS et al (2009) Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes. Mol Cell 35:806-817
64. Lehmann JM, Kliewer SA, Moore LB et al (1997) Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272:3137-3140 (Pubitemid 27066798)
65. Li N, Salter RC, Ramji DP (2011) Molecular mechanisms underlying the inhibition of IFN-c-induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs. J Cell Biochem 112:675-683
66. Lu K, Lee MH, Hazard S et al (2001) Two genes that map to the STSL locus cause sitosterolemia: Genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet 69:278-290 (Pubitemid 32695201)
67. Mangelsdorf DJ, Thummel C, Beato M et al (1995) The nuclear receptor superfamily: The second decade. Cell 83:835-839
68. Marathe C, Bradley MN, Hong C et al (2006) The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J Biol Chem 281:32197-32206 (Pubitemid 46036774)
69. Meng ZX, Nie J, Ling JJ et al (2009) Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Diabetologia 52:125-135
70. Mitro N, Mak PA, Vargas L et al (2007) The nuclear receptor LXR is a glucose sensor. Nature 445:219-223 (Pubitemid 46095727)
71. Moazed TC, Campbell LA, Rosenfeld ME et al (1999) Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis 180:238-241 (Pubitemid 29293945)
72. Molteni V, Li X, Nabakka J et al (2007) N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta. J Med Chem 50:4255-4259 (Pubitemid 47301757)
73. Morales JR, Ballesteros I, Deniz JM et al (2008) Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke. Circulation 118:1450-1459
74. Naiki Y, Sorrentino R, Wong MH et al (2008) TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J Immunol 181:7176-7185
75. Nunomura S, Endo K, Makishima M et al (2010) Oxysterol represses high-Affinity IgE receptor-stimulated mast cell activation in liver X receptor-dependent and -independent manners. FEBS Lett 584:1143-1148
76. Ogawa S, Lozach J, Jepsen K et al (2004) A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc Natl Acad Sci USA 101:14461-14466 (Pubitemid 39346771)
77. Ogawa S, Lozach J, Benner C et al (2005) Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122:707-721 (Pubitemid 41242636)
78. Palvimo JJ (2007) PIAS proteins as regulators of small ubiquitinrelated modifier (SUMO) modifications and transcription. Biochem Soc Trans 35(Pt 6):1405-1408
79. Park MC, Kwon YJ, Chung SJ et al (2010) Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. Rheumatology 49:882-890
80. Pascual G, Fong AL, Ogawa S et al (2005) A SUMOylationdependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437:759-763 (Pubitemid 41486547)
81. Pascual-García M, Carbó JM, León T et al (2011) Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4. J Immunol 186:4656-4667
82. Paterniti I, Genovese T, Mazzon E et al (2010) Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma. J Neurochem 112:611-624
83. Peet DJ, Turley SD, Ma W et al (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93:693-704 (Pubitemid 28257577)
84. Peyron P, Vaubourgeix J, Poquet Y et al (2008) Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4:e1000204
85. Plat J, Nichols JA, Mensink RP (2005) Plant sterols and stanols: Effects on mixed micellar composition and LXR (target gene) activation. J Lipid Res 46:2468-2476 (Pubitemid 41532535)
86. Poukka H, Karvonen U, Janne OA et al (2000) Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci USA 97:14145-14150 (Pubitemid 32016544)
87. Pourcet B, Feig JE, Vengrenyuk Y et al (2011) LXRa regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8. Circ Res 109:492-501
88. Quinet EM, Basso MD, Halpern AR et al (2009) LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. J Lipid Res 50:2358-2370
89. Repa JJ, Liang G, Ou J et al (2000a) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 14:2819-2830
90. Repa JJ, Turley SD, Lobaccaro JA et al (2000b) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289:1524-1529
91. Repa JJ, Berge KE, Pomajzl C et al (2002) Regulation of ATPbinding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277:18793-18800 (Pubitemid 34952438)
92. Ricart BG, John B, Lee D et al (2011) Dendritic cells distinguish individual chemokine signals through CCR7 and CXCR4. J Immunol 186:53-61
93. Ricote M, Valledor AF, Glass CK (2004) Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: Effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler Thromb Vasc Biol 24:230-239 (Pubitemid 38202188)
94. Schultz JR, Tu H, Luk A et al (2000) Role of LXRs in control of lipogenesis. Genes Dev 14:2831-2838
95. Scott RS, McMahon EJ, Pop SM et al (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411:207-211 (Pubitemid 32455181)
96. Singh SB, Ondeyka JG, Liu W et al (2005) Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters. Bioorg Med Chem Lett 15:2824-2828 (Pubitemid 40732228)
97. Sironi L, Mitro N, Cimino M et al (2008) Treatment with LXR agonists after focal cerebral ischemia prevents brain damage. FEBS Lett 582:3396-3400
98. Smoak K, Madenspacher J, Jeyaseelan S et al (2008) Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense. J Immunol 180:3305-3312
99. Song C, Liao S (2000) Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. Endocrinology 141:4180-4184
100. Terasaka N, Hiroshima A, Koieyama T et al (2003) T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett 536:6-11 (Pubitemid 36206397)
101. Terasaka N, Hiroshima A, Ariga A et al (2005) Liver X receptor agonists inhibit tissue factor expression in macrophages. FEBS J 272:1546-1556 (Pubitemid 40444942)
102. Tian S, Poukka H, Palvimo JJ et al (2002) Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem J 367(Pt 3):907-911 (Pubitemid 35305733)
103. Töröcsik D, Baráth M, Benko S et al (2010) Activation of liver X receptor sensitizes human dendritic cells to inflammatory stimuli. J Immunol 184:5456-5465
104. Torra IP, Ismaili N, Feig JE et al (2008) Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages. Mol Cell Biol 28:2626-2636 (Pubitemid 351542363)
105. Traves PG, Hortelano S, Zeini M et al (2007) Selective activation of liver X receptors by acanthoic acid-related diterpenes. Mol Pharmacol 71:1545-1553 (Pubitemid 47010907)
106. Treuter E, Venteclef N (2011) Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation. Biochim Biophys Acta 1812:909-918
107. Ullrich JW, Morris R, Bernotas RC et al (2010) Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists. Bioorg Med Chem Lett 20:2903-2907
108. Valledor AF, Hsu LC, Ogawa S et al (2004) Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA 101:17813-17818 (Pubitemid 40051969)
109. Vedin LL, Lewandowski SA, Parini P et al (2009) The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 30:575-579
110. Venkateswaran A, Repa JJ, Lobaccaro JM et al (2000) Human white/ murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J Biol Chem 275:14700-14707 (Pubitemid 30339762)
111. 2- dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Genes Dev 24:381-395
112. Villablanca EJ, Raccost L, Zhou D et al (2010) Tumor-mediated liver X receptor-Alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat Med 16:98-105
113. Wagner BL, Valledor AF, Shao G et al (2003) Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol 23:5780-5789 (Pubitemid 36951340)
114. Walczak R, Joseph SB, Laffitte BA et al (2004) Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors. J Biol Chem 279:9905-9911 (Pubitemid 38372590)
115. Wang YY, Dahle MK, Agren J et al (2006) Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation. Shock 25:141-146
116. Wang D, Liu M, Wang Y et al (2011) Synthetic LXR agonist TO901317 attenuates lipopolysaccharide-induced acute lung injury in rats. Int Immunopharmacol 11:2098-2103
117. Williams S, Bledsoe RK, Collins JL et al (2003) X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch. J Biol Chem 278:27138-27143 (Pubitemid 36876869)
118. Willy PJ, Umesono K, Ong ES et al (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:1033-1045
119. Yang C, McDonald JG, Patel A et al (2006) Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem 281:27816-27826 (Pubitemid 44414494)
120. Yu L, York J, von Bergmann K et al (2003) Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 278:15565-15570 (Pubitemid 36799664)
121. Zelcer N, Hong C, Boyadjian R et al (2009) LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325:100-104